Evidence map›Paper›PMID 32430352›Full record

ArticleBMJ case reports2020

Romiplostim for management of refractory immune thrombocytopenic purpura in the immediate postpartum period.

Ariana Patras, Reinaldo Figueroa, Amit P Singh, Ichchha Madan

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. ITP in pregnancy: diagnostics and therapeutics in 2024.Hematology. American Society of Hematology. Education Program · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ariana PatrasDepartment of OB/GYN, Trinity Health of New England, Hartford, Connecticut, USA.ORCID http://orcid.org/0000-0003-0135-4655
Reinaldo FigueroaDepartment of OB/GYN, Trinity Health of New England, Hartford, Connecticut, USA.
Amit P SinghDepartment of Nephrology, Trinity Health of New England, Mercy Medical Center, Springfield, Massachusetts, USA.
Ichchha MadanDepartment of OB/GYN, Trinity Health of New England, Hartford, Connecticut, USA ichchha.madan@yahoo.com.
Trinity Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a case of a pregnant woman with chronic immune thrombocytopenic purpura and chronic hypertension who developed pre-eclampsia with severe features warranting delivery. Her overall clinical picture and liver enzymes improved in the immediate postpartum period, however, aggressively progressing thrombocytopenia posed a diagnostic dilemma to the interdisciplinary care team. After failing to respond to first-line therapies including high-dose corticosteroids and intravenous immunoglobulin, she was successfully managed with a trial of the thrombopoietin receptor agonist, Romiplostim.

Indexed as

AdultDiagnosis, DifferentialFemaleHELLP SyndromeHumansPostpartum PeriodPregnancyPurpura, Thrombocytopenic, IdiopathicReceptors, FcReceptors, ThrombopoietinRecombinant Fusion ProteinsThrombopoietinTreatment OutcomeReceptors, FcReceptors, ThrombopoietinRecombinant Fusion ProteinsromiplostimThrombopoietinhaematology (incl blood transfusion)obstetrics, gynaecology and fertilitypregnancy

Identifiers

PMID32430352
PMCPMC7239498
OpenAlexW3027868517

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.